|
US5614545A
(en)
|
1988-06-09 |
1997-03-25 |
Leonard Bloom |
Topical composition for treatment of blepharitis
|
|
US4957918A
(en)
|
1988-06-09 |
1990-09-18 |
Leonard Bloom |
Topical treatment of blepharitis
|
|
AT393454B
(de)
|
1989-10-04 |
1991-10-25 |
Ido Dr Egerer |
Augentropfenzusatz
|
|
US6107289A
(en)
|
1992-04-21 |
2000-08-22 |
The Schepens Eye Research Institute, Inc. |
Ocular therapy in keratoconjunctivitis sicca using topically applied androgens or TGF-β
|
|
US6239113B1
(en)
|
1999-03-31 |
2001-05-29 |
Insite Vision, Incorporated |
Topical treatment or prevention of ocular infections
|
|
RU2004118424A
(ru)
|
2001-11-19 |
2005-05-10 |
Новартис АГ (CH) |
Применение аскомицина для лечения блефарита
|
|
AR042890A1
(es)
|
2003-01-16 |
2005-07-06 |
Sucampo Pharmaceuticals Inc |
Metodo de tratamiento del ojo seco con una composicion oftalmica que contiene un compuesto macrolido
|
|
KR20050092429A
(ko)
|
2003-01-22 |
2005-09-21 |
니찌방 가부시기가이샤 |
안질환 치료용 경피 흡수형 제제, 그 사용, 및 안질환치료약의 눈의 국소 조직으로의 이행 방법
|
|
CA2597525A1
(en)
|
2005-02-17 |
2006-08-24 |
Senju Pharmaceutical Co., Ltd. |
Solid ophthalmic drug for external use
|
|
US20070004672A1
(en)
|
2005-07-01 |
2007-01-04 |
Dharmendra Jani |
Long lasting alginate dry eye, related methods of manufacture and methods of use
|
|
FR2891460B1
(fr)
|
2005-09-30 |
2010-07-30 |
Galderma Sa |
Utilisation d'au moins un compose de la famille des avermectines pour le traitement des pathologies ophtalmiques dues au demodex folliculorum.
|
|
EP1964575B1
(en)
|
2005-11-28 |
2015-09-23 |
Senju Pharmaceutical Co., Ltd. |
Pharmaceutical comprising ppar agonist
|
|
US20090318422A1
(en)
|
2006-08-28 |
2009-12-24 |
Akiharu Isowaki |
Ophthalmic percutaneous absorption type preparation
|
|
US20080057022A1
(en)
|
2006-08-30 |
2008-03-06 |
Erning Xia |
Ophthalmic Pharmaceutical Compositions and Uses Thereof
|
|
US7659259B2
(en)
|
2006-12-21 |
2010-02-09 |
Bausch & Lomb Incorporated |
Method of treating inflammation of the eye
|
|
US20080312194A1
(en)
|
2007-02-28 |
2008-12-18 |
Ousler Iii George W |
Methods and compositions for normalizing meibomian gland secretions
|
|
CA2685230C
(en)
*
|
2007-05-04 |
2012-10-16 |
Bausch & Lomb Incorporated |
Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same
|
|
WO2008137826A2
(en)
|
2007-05-07 |
2008-11-13 |
Bausch & Lomb Incorporated |
Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same
|
|
CA2753844A1
(en)
|
2008-03-05 |
2009-09-11 |
Vicus Therapeutics, Llc |
Compositions and methods for mucositis and oncology therapies
|
|
US20110059925A1
(en)
|
2008-03-26 |
2011-03-10 |
Eric Donnenfeld |
Methods for improving lid margin and tear film function and treatment of lid margin disease using tetracycline family antibiotics
|
|
MX2011000247A
(es)
*
|
2008-07-10 |
2011-03-30 |
Inspire Pharmaceuticals Inc |
Composicion farmaceutica para el tratamiento de blefaritis.
|
|
WO2010085572A1
(en)
|
2009-01-23 |
2010-07-29 |
Inspire Pharmaceuticals, Inc. |
Method of treating dry eye disease with azithromycin
|
|
FR2942138A1
(fr)
|
2009-02-16 |
2010-08-20 |
Galderma Res & Dev |
Association de composes pour le traitement ou la prevention des affections dermatologiques
|
|
ES2752008T3
(es)
|
2009-10-30 |
2020-04-02 |
Intratus Inc |
Métodos y composiciones para la liberación sostenida de fármacos
|
|
WO2011068786A2
(en)
|
2009-12-02 |
2011-06-09 |
Bridge Pharma, Inc. |
Treating xerophthalmia with compounds increasing meibomian gland secretion
|
|
US9011861B2
(en)
*
|
2010-02-25 |
2015-04-21 |
Schepens Eye Research Institute |
Therapeutic compositions for the treatment of dry eye disease
|
|
AU2011287544B2
(en)
|
2010-08-06 |
2014-12-11 |
Galderma Research & Development |
Combination of compounds for treating or preventing skin diseases
|
|
WO2012092375A1
(en)
|
2010-12-29 |
2012-07-05 |
Inspire Pharmaceuticals, Inc. |
Method for treating dry eye
|
|
US8900626B2
(en)
|
2011-06-20 |
2014-12-02 |
Senju Usa, Inc. |
Transdermal drug delivery system and method of using the same
|
|
WO2013003731A2
(en)
|
2011-06-29 |
2013-01-03 |
Insite Vision Incorporated |
Methods of treating recurrent meibomian glands disorder and thereby decreasing the frequency of recurrence
|
|
CA2848397C
(en)
*
|
2011-09-14 |
2022-04-26 |
Forsight Vision5, Inc. |
Ocular insert apparatus and methods
|
|
EP2895144B1
(en)
|
2012-09-12 |
2017-01-11 |
Novaliq GmbH |
Semifluorinated alkane compositions
|
|
MX363182B
(es)
|
2012-09-12 |
2019-03-13 |
Novaliq Gmbh |
Composiciones que comprenden mezclas de alcanos semifluorados.
|
|
CA2886042C
(en)
|
2012-09-28 |
2015-11-24 |
Santen Pharmaceutical Co., Ltd. |
Therapeutic or preventive agent for meibomian gland dysfunction or meibomian gland blockage
|
|
US9044508B2
(en)
|
2013-03-15 |
2015-06-02 |
Insite Vision Corporation |
Concentrated aqueous azalide formulations
|
|
US20150141328A1
(en)
*
|
2013-11-18 |
2015-05-21 |
The Schepens Eye Research Institute |
Stimulation of human meibomian gland function
|
|
US20170232024A1
(en)
|
2014-08-04 |
2017-08-17 |
Jerry Tan Eye Surgery Pte Ltd |
Pharmaceutical compositions for demodex related blepharitis and eyelid crusting
|
|
US9931306B2
(en)
*
|
2014-09-06 |
2018-04-03 |
Integral Biosystems Llc |
Methods and biocompatible compositions to achieve sustained drug release in the eye
|
|
US9597328B2
(en)
*
|
2015-02-24 |
2017-03-21 |
Ocugen, Inc. |
Methods and compositions for treating dry eye disease and other eye disorders
|
|
US9393243B1
(en)
|
2015-07-14 |
2016-07-19 |
Nilesh Parikh |
Topical Ciprofloxacin compositions
|
|
WO2017055924A2
(en)
|
2015-09-28 |
2017-04-06 |
M.G. Therapeutics Ltd. |
Thiol and disulfide-containing agents for increasing meibomian gland lipid secretion
|
|
FR3041540B1
(fr)
|
2015-09-29 |
2018-10-26 |
Galderma Research & Development |
Composition nettoyante auto-moussante a rincer, contenant de l'ivermectine.
|
|
WO2017089980A1
(en)
|
2015-11-26 |
2017-06-01 |
Cadila Healthcare Limited |
Dual ppar modulators for the treatment of diabetic retinopathy and diabetic eye diseases
|
|
GB201522144D0
(en)
|
2015-12-15 |
2016-01-27 |
Univ Manchester |
Compositions and uses and methods relating thereto
|
|
US9439917B1
(en)
|
2015-12-28 |
2016-09-13 |
Shetal Amit Shah |
Anti-blepharitis compositions and their use
|
|
EA201891743A1
(ru)
|
2016-02-04 |
2019-01-31 |
Гордон Уэйн Дайер |
Способ нарушения состояния касси-бакстера
|
|
US11260035B2
(en)
|
2016-10-12 |
2022-03-01 |
Ps Therapies Ltd |
Topical compositions and methods of use thereof
|
|
EP3326608A1
(en)
|
2016-11-24 |
2018-05-30 |
Nestlé Skin Health SA |
Composition comprising avermectin compounds without solid fatty substances
|
|
GB201706969D0
(en)
|
2017-05-02 |
2017-06-14 |
Medherant Ltd |
Formulation
|
|
US20190008920A1
(en)
*
|
2017-05-19 |
2019-01-10 |
Ocugen, Inc. |
Ophthalmic compositions and methods of use
|
|
EP3644966A4
(en)
|
2017-06-29 |
2021-03-24 |
Advaite LLC |
TREATMENT AND DIAGNOSIS OF EYE SURFACE DISORDERS
|
|
CA3080166A1
(en)
|
2017-11-21 |
2019-05-31 |
Axerovision, Inc. |
Compositions and methods of use for treating aberrant inflammation in peri-ocular secretory glands or at the ocular surface
|
|
WO2019113475A1
(en)
|
2017-12-07 |
2019-06-13 |
Dermavant Sciences GmbH |
Topical ointment formulations and their use in treating skin conditions
|
|
WO2020077284A1
(en)
|
2018-10-12 |
2020-04-16 |
Hovione Scientia |
Macrocyclic lactone formulations, methods of their preparation and use of the formulations in treating pathologies secondary to ophthalmic parasites
|
|
US12161752B2
(en)
*
|
2019-08-20 |
2024-12-10 |
Vishwanath Padmanabhan |
Compositions and methods for the treatment of anterior blepharitis and posterior blepharitis
|
|
US20210052493A1
(en)
|
2019-08-21 |
2021-02-25 |
Joseph Sinclair |
Non-aqueous anti-parasitic ointment for ophthalmological use
|
|
WO2021067823A2
(en)
|
2019-10-05 |
2021-04-08 |
The Schepens Eye Research Institute, Inc. |
A new treatment for meibomian gland dysfunction
|
|
WO2021087051A1
(en)
|
2019-10-30 |
2021-05-06 |
Ps Therapy Ltd. |
Topical compositions and methods of use thereof
|
|
US20220160668A1
(en)
|
2020-11-23 |
2022-05-26 |
Sight Sciences, Inc. |
Formulations and methods for treating conditions of the eye
|
|
US11872213B2
(en)
|
2021-01-28 |
2024-01-16 |
Glaukos Corporation |
Formulations
|